Real world use of ixekizumab is associated with reductions in concomitant medications among biologic-experienced or biologic-naive patients with psoriasis

被引：0
|
作者：
Wu, Jashin J. [1 ]
Zhu, Baojin [2 ]
Burge, Russel [2 ]
Goldblum, Orin [2 ]
Choong, Casey [2 ]
Edson-Heredia, Emily [2 ]
Amato, David [2 ]
机构：
[1] Dermatol Res & Educ Fdn, Irvine, CA USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
9884
引用
收藏
页码：AB114 / AB114
页数：1
相关论文
共 50 条
  • [41] Utilization Trends and Impact of Secukinumab Treatment on Clinical Outcomes in Biologic-Naive Patients with Psoriasis in a US Real-World Setting
    Bruce Strober
    Dhaval Patil
    Robert R. McLean
    Melissa Moore-Clingenpeel
    Ning Guo
    Eugenia Levi
    Mark Lebwohl
    Dermatology and Therapy, 2022, 12 : 1351 - 1365
  • [42] COMPARISON OF TREATMENT SWITCHING AMONG BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGIC TREATMENT: RESULTS FROM A US CLAIMS DATABASE
    Kaplan, D.
    Ung, B.
    Pelletier, C.
    Udeze, C.
    Tian, M.
    VALUE IN HEALTH, 2019, 22 : S364 - S364
  • [43] Efficacy and safety of ixekizumab at week 24 in biologic-experienced patients with active psoriatic arthritis: summary results
    Marzo-Ortega, H.
    Meroni, P.
    Galindez-Agirregoikoa, E.
    Behrens, F.
    Bradley, A.
    Leage, S. Liu
    Garcia, M.
    Sapin, C.
    Ho, J.
    Constantin, A.
    Hall, S.
    Porsdal, V.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 : 43 - 44
  • [44] Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis
    Klavdianou, Kalliopi
    Lazarini, Argyro
    Grivas, Alexandros
    Tseronis, Dimitrios
    Tsalapaki, Christina
    Rapsomaniki, Panagiota
    Antonatou, Katerina
    Thomas, Konstantinos
    Boumpas, Dimitrios
    Katsimbri, Pelagia
    Vassilopoulos, Dimitrios
    FRONTIERS IN MEDICINE, 2020, 7
  • [45] Endoscopic and Clinical Efficacy Demonstrated with Oral Ozanimod in Active Crohn's Disease in Biologic-Naive and Biologic Experienced Patients
    Brian, Feagan
    William, Sandborn
    Silvio, Danese
    Geert, D'Haens
    Barrett, Levesque
    Brett, Skolnick
    David, Paul
    Richard, Aranda
    Allan, Olson
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S3 - S3
  • [46] REAL-WORLD INTERRUPTIONS IN JANUS KINASE INHIBITOR THERAPY OBSERVED AMONG BIOLOGICNAIVE AND BIOLOGIC-EXPERIENCED RHEUMATOID ARTHRITIS PATIENTS
    Chastek, B.
    Koep, E.
    Mallya, U. G.
    Cockerham, A.
    Choi, J.
    Boklage, S.
    Furst, D. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 949 - 950
  • [47] Real world tumor necrosis factor (TNF) blocker treatment patterns for biologic-naive psoriasis patients in a US managed care population
    Smith, Timothy
    Joyce, Amie
    Fox, Kathleen
    Gandra, Shravanthi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB10 - AB10
  • [48] Clinical and Radiographic Efficacy of Sarilumab Plus Methotrexate in Biologic-Experienced and Biologic-Naive Patients with Rheumatoid Arthritis in a Phase 3, Randomized, Double-blind, Placebo-Controlled Study
    Fiore, Stefano
    Genovese, Mark
    Fan, Chunpeng
    Decktor, Dennis
    Fleischmann, Roy
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1217 - 1217
  • [49] Persistence and Failure Rates of Monotherapy Etanercept in Biologic-Naive Psoriasis Patients: A Retrospective Study
    Reddy, Shivani P.
    Shah, Vidhi V.
    Lin, Elaine J.
    Egeberg, Alexander
    Wu, Jashin J.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (08) : 1029 - 1030
  • [50] Ixekizumab Demonstrates Improvement Comparable to Adalimumab Across ACR Components in Biologic-Naive Patients with Psoriatic Arthritis
    Husni, M. Elaine
    Gowin, Kristin
    Gellett, Amanda
    Sprabery, Aubrey Trevelin
    Helt, Cameron
    Geneus, Vladimir
    Rossini, Maurizio
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345